Question 1

What are the different markets in which
        BioClinica and
        Advarra Oncore compete against each other?

Accepted Answer

BioClinica and
        Advarra Oncore compete against each other in
        the Clinical Trial Management System (CTMS).

Question 2

How does the market share of
        BioClinica
        and Advarra Oncore compare in the
        Clinical Trial Management System (CTMS) market?

Accepted Answer

In the Clinical Trial Management System (CTMS) market,
        BioClinica has a
        15.22%
        market share in comparison to
        Advarra Oncore’s
        5.14%.
        Since it has a better market share coverage,
        BioClinica holds the
        3rd
        spot in 6sense's Market Share Ranking Index for
        the Clinical Trial Management System (CTMS) category, while
        Advarra Oncore holds the
        5th spot.

Question 3

How many customers are acquired by
        BioClinica and
        Advarra Oncore in the
        Clinical Trial Management System (CTMS) segment?

Accepted Answer

BioClinica has
        77 customers and
        Advarra Oncore has
        26 customers in the
        Clinical Trial Management System (CTMS)
        segment. BioClinica has
        51 more customers than
        Advarra Oncore in this category.

Question 4

What are the countries in which
        BioClinica and
        Advarra Oncore has more customers?

Accepted Answer

BioClinica has more customers in United States, India and Germany.
Advarra Oncore has more customers in and United States.

BioClinica Vs Advarra Oncore : In-Depth Comparison

Choose Technologies to compare

Comparing the customer bases of BioClinica and Advarra Oncore

Comparing the market share of BioClinica and Advarra Oncore

Compare BioClinica vs Advarra Oncore customers by geography

Customer Movements for this month

FAQ

Choose Technologies to compare

Save 15 hours a week on sales research

Get instant access to B2B contact data across the web

Company

Browse 6sense Data